Company Overview - Vistin Pharma ASA is a Norwegian pharmaceutical company specializing in the production of Metformin Hydrochloride (API) and Direct Compressible lubricated granules [3] - The company is a dedicated European Metformin producer, positioning itself as a key supplier to leading pharmaceutical companies [3] Upcoming Financial Results - Vistin Pharma will release its second quarter and year-to-date 2025 results on August 15, 2025 [1] - A conference call for shareholders and interested parties will take place on the same day at 08:30 CET, including a Q&A session following the management discussion [1] Communication Channels - The conference call will be accessible via web and audio through specified access points [1] - Webcast and telephone conference registration links are provided for participants [2]